Bilateral, multiple, episodic retinal vein occlusions associated with common variable immunodeficiency

JAMA Ophthalmol. 2015 Oct;133(10):1216-8. doi: 10.1001/jamaophthalmol.2015.2414.

Authors

Ian C Han¹, Lawrence J Singerman², Alvin Schmaier³, Neil M Bressler⁴

Affiliations

¹ Retina Division, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland.
² Retina Associates of Cleveland, Cleveland, Ohio.
³ Case Western Reserve University, University Hospitals Case Medical Center, Cleveland, Ohio.
⁴ Retina Division, Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, Maryland4Editor, JAMA Ophthalmology.

PMID: 26226509
DOI: 10.1001/jamaophthalmol.2015.2414

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Angiogenesis Inhibitors / therapeutic use
Bevacizumab / therapeutic use
Child
Common Variable Immunodeficiency / complications*
Female
Fluorescein Angiography
Follow-Up Studies
Humans
Immunoglobulin M / blood
Intravitreal Injections
Laser Coagulation
Macular Edema / drug therapy
Macular Edema / etiology
Retinal Neovascularization / etiology
Retinal Neovascularization / surgery
Retinal Vein Occlusion / diagnosis
Retinal Vein Occlusion / etiology*
Retinal Vein Occlusion / therapy
Vascular Endothelial Growth Factor A / antagonists & inhibitors

Substances

Angiogenesis Inhibitors
Immunoglobulin M
VEGFA protein, human
Vascular Endothelial Growth Factor A
Bevacizumab